PMDA drug package insert
パルミコート吸入液0.25mg
PMDA Prescription drug · アストラゼネカ株式会社 · package insert Jan 10, 2024
Key facts
| Brand names | パルミコート吸入液0.25mg, パルミコート吸入液0.5mg |
|---|---|
| Nonproprietary names | ブデソニド |
| Companies | 製造販売元／アストラゼネカ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 吸入ステロイド喘息治療剤 |
| Therapeutic category codes | 87229 |
| YJ codes | 2290701G4020, 2290701G5026 |
| Approval numbers | 21800AMY10113, 21800AMY10114 |
| Package insert edition | 第2版 |
| Package insert date | Jan 10, 2024 |
| PMDA document key | 670227_2290701G4020_1 |
| PMDA company code | 670227 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: